Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.54325444 |
2 | detection of molecule of bacterial origin (GO:0032490) | 4.25211859 |
3 | neutrophil activation involved in immune response (GO:0002283) | 4.16520669 |
4 | response to peptidoglycan (GO:0032494) | 4.09004380 |
5 | T cell migration (GO:0072678) | 4.07138561 |
6 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.00062786 |
7 | neutrophil mediated immunity (GO:0002446) | 3.95652282 |
8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.89758832 |
9 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.85952370 |
10 | positive regulation by symbiont of host defense response (GO:0052509) | 3.83890492 |
11 | modulation by symbiont of host defense response (GO:0052031) | 3.83890492 |
12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.83890492 |
13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.83890492 |
14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.83890492 |
15 | modulation by symbiont of host immune response (GO:0052553) | 3.83890492 |
16 | regulation of activation of Janus kinase activity (GO:0010533) | 3.83783002 |
17 | positive regulation of heat generation (GO:0031652) | 3.82151575 |
18 | protein localization to endosome (GO:0036010) | 3.81106312 |
19 | respiratory burst (GO:0045730) | 3.65885983 |
20 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.61298565 |
21 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.55922930 |
22 | response to muramyl dipeptide (GO:0032495) | 3.49508789 |
23 | leukocyte aggregation (GO:0070486) | 3.47304924 |
24 | positive regulation of interferon-alpha production (GO:0032727) | 3.44637589 |
25 | myeloid dendritic cell activation (GO:0001773) | 3.39258880 |
26 | myeloid dendritic cell differentiation (GO:0043011) | 3.39025540 |
27 | granulocyte activation (GO:0036230) | 3.35628270 |
28 | regulation of fever generation (GO:0031620) | 3.35147624 |
29 | cellular response to zinc ion (GO:0071294) | 3.34446442 |
30 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.33616123 |
31 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.33526796 |
32 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.31537745 |
33 | heterotypic cell-cell adhesion (GO:0034113) | 3.30246222 |
34 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.30157513 |
35 | regulation of interferon-alpha production (GO:0032647) | 3.29464395 |
36 | monocyte chemotaxis (GO:0002548) | 3.29129341 |
37 | neutrophil activation (GO:0042119) | 3.25793623 |
38 | interferon-gamma production (GO:0032609) | 3.18290588 |
39 | positive regulation of interleukin-12 production (GO:0032735) | 3.17546226 |
40 | negative regulation of interleukin-12 production (GO:0032695) | 3.17540104 |
41 | germinal center formation (GO:0002467) | 3.13687542 |
42 | defense response to protozoan (GO:0042832) | 3.13287114 |
43 | negative regulation of interleukin-17 production (GO:0032700) | 3.11526919 |
44 | embryonic process involved in female pregnancy (GO:0060136) | 3.10672973 |
45 | cellular response to interferon-beta (GO:0035458) | 3.09867114 |
46 | myeloid leukocyte mediated immunity (GO:0002444) | 3.08094286 |
47 | leukocyte cell-cell adhesion (GO:0007159) | 3.04456912 |
48 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.03495452 |
49 | nuclear pore complex assembly (GO:0051292) | 3.02692597 |
50 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.02533055 |
51 | negative regulation of cell killing (GO:0031342) | 3.02533055 |
52 | iron ion import (GO:0097286) | 3.02481627 |
53 | positive regulation of leukocyte degranulation (GO:0043302) | 3.02437906 |
54 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.00992458 |
55 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.98357649 |
56 | positive regulation of interferon-beta production (GO:0032728) | 2.94491125 |
57 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.92762630 |
58 | response to protozoan (GO:0001562) | 2.92325532 |
59 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.92316537 |
60 | detection of external biotic stimulus (GO:0098581) | 2.91712610 |
61 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.90936063 |
62 | response to host immune response (GO:0052572) | 2.90936063 |
63 | regulation of chronic inflammatory response (GO:0002676) | 2.89972625 |
64 | wound healing, spreading of epidermal cells (GO:0035313) | 2.89429447 |
65 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.88666834 |
66 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.88159558 |
67 | cellular extravasation (GO:0045123) | 2.86983521 |
68 | NIK/NF-kappaB signaling (GO:0038061) | 2.85567516 |
69 | immunoglobulin mediated immune response (GO:0016064) | 2.85064615 |
70 | oligosaccharide catabolic process (GO:0009313) | 2.84927096 |
71 | positive regulation of interleukin-10 production (GO:0032733) | 2.84453255 |
72 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.84387488 |
73 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.84350429 |
74 | positive regulation of interleukin-2 production (GO:0032743) | 2.84196632 |
75 | response to host (GO:0075136) | 2.83994630 |
76 | response to host defenses (GO:0052200) | 2.83994630 |
77 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.83994630 |
78 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.83689962 |
79 | regulation of fibroblast apoptotic process (GO:2000269) | 2.82780689 |
80 | regulation of heat generation (GO:0031650) | 2.82474720 |
81 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.82354364 |
82 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.81093620 |
83 | myeloid cell activation involved in immune response (GO:0002275) | 2.79918565 |
84 | leukocyte mediated cytotoxicity (GO:0001909) | 2.79583630 |
85 | regulation of early endosome to late endosome transport (GO:2000641) | 2.78999321 |
86 | regulation of macrophage cytokine production (GO:0010935) | 2.75435158 |
87 | negative T cell selection (GO:0043383) | 2.75402365 |
88 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.75045311 |
89 | positive regulation of antigen processing and presentation (GO:0002579) | 2.74853426 |
90 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.74459332 |
91 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.73827729 |
92 | lymphocyte chemotaxis (GO:0048247) | 2.72831850 |
93 | negative regulation by host of viral transcription (GO:0043922) | 2.72308764 |
94 | positive regulation of macrophage cytokine production (GO:0060907) | 2.70900059 |
95 | macrophage activation involved in immune response (GO:0002281) | 2.70543019 |
96 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.70443126 |
97 | membrane raft organization (GO:0031579) | 2.69657734 |
98 | macrophage activation (GO:0042116) | 2.69568897 |
99 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.69328086 |
100 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.68975606 |
101 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.68936286 |
102 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.68071593 |
103 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.68048321 |
104 | lymphocyte migration (GO:0072676) | 2.68028270 |
105 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.67995863 |
106 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.67786378 |
107 | stress fiber assembly (GO:0043149) | 2.67468942 |
108 | regulation of chemokine biosynthetic process (GO:0045073) | 2.67009208 |
109 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.66884900 |
110 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.65256122 |
111 | natural killer cell mediated immunity (GO:0002228) | 2.65256122 |
112 | Rap protein signal transduction (GO:0032486) | 2.64237021 |
113 | detection of other organism (GO:0098543) | 2.62367681 |
114 | low-density lipoprotein particle clearance (GO:0034383) | 2.61717927 |
115 | positive regulation of isotype switching (GO:0045830) | 2.61499811 |
116 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.61441082 |
117 | T-helper cell differentiation (GO:0042093) | 2.61441082 |
118 | negative thymic T cell selection (GO:0045060) | 2.59016020 |
119 | positive regulation of chemokine production (GO:0032722) | 2.58352058 |
120 | regulation of interleukin-17 production (GO:0032660) | 2.58347765 |
121 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.58063747 |
122 | T-helper 1 type immune response (GO:0042088) | 2.57875067 |
123 | hepatocyte apoptotic process (GO:0097284) | 2.57473291 |
124 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.57377799 |
125 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.57222096 |
126 | myeloid leukocyte activation (GO:0002274) | 2.56599297 |
127 | positive regulation of leukocyte apoptotic process (GO:2000108) | 2.56461597 |
128 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.56389537 |
129 | pinocytosis (GO:0006907) | 2.56290126 |
130 | cytokine secretion (GO:0050663) | 2.55960246 |
131 | glycosphingolipid catabolic process (GO:0046479) | 2.55455586 |
132 | mammary gland epithelial cell proliferation (GO:0033598) | 2.55145235 |
133 | regulation of interleukin-12 production (GO:0032655) | 2.54532824 |
134 | T cell activation involved in immune response (GO:0002286) | 2.54288199 |
135 | regulation of memory T cell differentiation (GO:0043380) | 2.54053793 |
136 | regulation of leukocyte degranulation (GO:0043300) | 2.53943951 |
137 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.52039137 |
138 | hypotonic response (GO:0006971) | 2.49851422 |
139 | mRNA transcription (GO:0009299) | 2.47246739 |
140 | response to thyroid hormone (GO:0097066) | 2.46234797 |
141 | establishment of endothelial barrier (GO:0061028) | 2.45207895 |
142 | response to laminar fluid shear stress (GO:0034616) | 2.43250666 |
143 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.42954830 |
144 | cell adhesion mediated by integrin (GO:0033627) | 2.42691163 |
145 | detection of biotic stimulus (GO:0009595) | 2.41993400 |
146 | regulation of podosome assembly (GO:0071801) | 2.36027183 |
147 | nuclear pore organization (GO:0006999) | 2.35576822 |
148 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.34535404 |
149 | microglial cell activation (GO:0001774) | 2.33210466 |
150 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.32520126 |
151 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.30468112 |
152 | positive regulation of receptor recycling (GO:0001921) | 2.29661730 |
153 | pore complex assembly (GO:0046931) | 2.28308505 |
154 | regulation of necroptotic process (GO:0060544) | 2.26788321 |
155 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.26655623 |
156 | positive regulation of regulated secretory pathway (GO:1903307) | 2.26428276 |
157 | glycolipid catabolic process (GO:0019377) | 2.25979009 |
158 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.25318928 |
159 | modulation by symbiont of host cellular process (GO:0044068) | 2.23879153 |
160 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.23824859 |
161 | peptide catabolic process (GO:0043171) | 2.23261182 |
162 | COPI coating of Golgi vesicle (GO:0048205) | 2.22199071 |
163 | Golgi transport vesicle coating (GO:0048200) | 2.22199071 |
164 | cellular response to arsenic-containing substance (GO:0071243) | 2.21667741 |
165 | regulation of gamma-delta T cell activation (GO:0046643) | 2.19667762 |
166 | cellular protein complex localization (GO:0034629) | 2.17960243 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.17040171 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.48139267 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.31834754 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.29275711 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.86533491 |
6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.87828228 |
7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.79026745 |
8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.49967781 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.48315860 |
10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.47274411 |
11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.25908375 |
12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.19401336 |
13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.97455371 |
14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.85755300 |
15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.84767891 |
16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.82610089 |
17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.81658509 |
18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.70845467 |
19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.62324889 |
20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.50262765 |
21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.40392187 |
22 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.22908467 |
23 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.22897407 |
24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.17222594 |
25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.17193267 |
26 | MYB_26560356_Chip-Seq_TH2_Human | 2.02329649 |
27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.96040127 |
28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95898936 |
29 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.93415555 |
30 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.91091989 |
31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.89322186 |
32 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.88812349 |
33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.82492460 |
34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.81112800 |
35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.74760089 |
36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69015414 |
37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.63833567 |
38 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.61512326 |
39 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.58876597 |
40 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.58612264 |
41 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.58583790 |
42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57629811 |
43 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.57247468 |
44 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.57030349 |
45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.56160812 |
46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.54680692 |
47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54139981 |
48 | MYB_26560356_Chip-Seq_TH1_Human | 1.47948912 |
49 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.47238247 |
50 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46124217 |
51 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.45748880 |
52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.44567720 |
53 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.42497208 |
54 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41494341 |
55 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.41396487 |
56 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.41298969 |
57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40023695 |
58 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38793733 |
59 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.38602623 |
60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.37116589 |
61 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.36318118 |
62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.36215249 |
63 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.36095044 |
64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36016518 |
65 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34471833 |
66 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.33736670 |
67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.32794897 |
68 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.32647164 |
69 | MAF_26560356_Chip-Seq_TH1_Human | 1.32339134 |
70 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.32254947 |
71 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.26757658 |
72 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.25282186 |
73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23794151 |
74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22740252 |
75 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.22435737 |
76 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20817932 |
77 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20638700 |
78 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20354602 |
79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18482802 |
80 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.17433543 |
81 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14232888 |
82 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.12864636 |
83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12575700 |
84 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.10672695 |
85 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10066895 |
86 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.10043288 |
87 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.09948570 |
88 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09498943 |
89 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07988849 |
90 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07086477 |
91 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06712018 |
92 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.05821513 |
93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05757693 |
94 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05655824 |
95 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05562838 |
96 | GATA1_22025678_ChIP-Seq_K562_Human | 1.04987345 |
97 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.03467046 |
98 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03376849 |
99 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.02233101 |
100 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02145739 |
101 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00924812 |
102 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00310893 |
103 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99376287 |
104 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98092961 |
105 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.97702016 |
106 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97678178 |
107 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.97420432 |
108 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97340702 |
109 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96470638 |
110 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96168447 |
111 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.95658313 |
112 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94770716 |
113 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94770716 |
114 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94460231 |
115 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93904414 |
116 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92897742 |
117 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92859696 |
118 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92268345 |
119 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92120335 |
120 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.89191527 |
121 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.88406159 |
122 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.84497714 |
123 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.84497714 |
124 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84161814 |
125 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.83583656 |
126 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81364256 |
127 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.81130825 |
128 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.79226241 |
129 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.77395143 |
130 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.76679756 |
131 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.73927699 |
132 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.73646357 |
133 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.72858201 |
134 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71133005 |
135 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.70739166 |
136 | UTX_26944678_Chip-Seq_JUKART_Human | 0.70480472 |
137 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69591782 |
138 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.68385656 |
139 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.68382570 |
140 | MYC_22102868_ChIP-Seq_BL_Human | 0.65480465 |
141 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.65087036 |
142 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.63471784 |
143 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.63169891 |
144 | TP53_16413492_ChIP-PET_HCT116_Human | 0.62814019 |
145 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.62400020 |
146 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.61082852 |
147 | EWS_26573619_Chip-Seq_HEK293_Human | 0.59787333 |
148 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.59139802 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.56288945 |
2 | MP0009785_altered_susceptibility_to | 3.43457501 |
3 | MP0005000_abnormal_immune_tolerance | 3.13764582 |
4 | MP0002148_abnormal_hypersensitivity_rea | 3.10621721 |
5 | MP0005451_abnormal_body_composition | 3.01868989 |
6 | MP0002419_abnormal_innate_immunity | 2.95300427 |
7 | MP0003436_decreased_susceptibility_to | 2.94528871 |
8 | MP0005671_abnormal_response_to | 2.90610908 |
9 | MP0003191_abnormal_cellular_cholesterol | 2.87761184 |
10 | MP0002452_abnormal_antigen_presenting | 2.58807259 |
11 | MP0003448_altered_tumor_morphology | 2.50754812 |
12 | MP0005025_abnormal_response_to | 2.49758833 |
13 | MP0002006_tumorigenesis | 2.45043618 |
14 | MP0002723_abnormal_immune_serum | 2.41356931 |
15 | MP0000685_abnormal_immune_system | 2.40114693 |
16 | MP0001790_abnormal_immune_system | 2.35602568 |
17 | MP0005387_immune_system_phenotype | 2.35602568 |
18 | MP0001800_abnormal_humoral_immune | 2.34549568 |
19 | MP0001819_abnormal_immune_cell | 2.32081964 |
20 | MP0002420_abnormal_adaptive_immunity | 2.31585127 |
21 | MP0004185_abnormal_adipocyte_glucose | 2.15774514 |
22 | MP0003303_peritoneal_inflammation | 2.14396585 |
23 | MP0006082_CNS_inflammation | 2.10744756 |
24 | MP0002009_preneoplasia | 2.04913152 |
25 | MP0010352_gastrointestinal_tract_polyps | 2.04433092 |
26 | MP0003705_abnormal_hypodermis_morpholog | 1.99918495 |
27 | MP0001853_heart_inflammation | 1.99185313 |
28 | MP0002405_respiratory_system_inflammati | 1.96933550 |
29 | MP0008057_abnormal_DNA_replication | 1.95970307 |
30 | MP0004510_myositis | 1.95321925 |
31 | MP0010234_abnormal_vibrissa_follicle | 1.90280394 |
32 | MP0000858_altered_metastatic_potential | 1.90220739 |
33 | MP0000569_abnormal_digit_pigmentation | 1.87296977 |
34 | MP0003763_abnormal_thymus_physiology | 1.86282684 |
35 | MP0002166_altered_tumor_susceptibility | 1.85127673 |
36 | MP0008260_abnormal_autophagy | 1.84453038 |
37 | MP0005666_abnormal_adipose_tissue | 1.83732640 |
38 | MP0003724_increased_susceptibility_to | 1.82788732 |
39 | MP0004947_skin_inflammation | 1.81069467 |
40 | MP0009333_abnormal_splenocyte_physiolog | 1.77637839 |
41 | MP0002398_abnormal_bone_marrow | 1.75550812 |
42 | MP0009840_abnormal_foam_cell | 1.74835809 |
43 | MP0002933_joint_inflammation | 1.73356981 |
44 | MP0005464_abnormal_platelet_physiology | 1.69191096 |
45 | MP0000716_abnormal_immune_system | 1.67590272 |
46 | MP0001533_abnormal_skeleton_physiology | 1.66459816 |
47 | MP0001845_abnormal_inflammatory_respons | 1.53244687 |
48 | MP0004233_abnormal_muscle_weight | 1.53010698 |
49 | MP0003828_pulmonary_edema | 1.46772138 |
50 | MP0003656_abnormal_erythrocyte_physiolo | 1.45729712 |
51 | MP0003221_abnormal_cardiomyocyte_apopto | 1.41492693 |
52 | MP0009764_decreased_sensitivity_to | 1.40502118 |
53 | MP0006054_spinal_hemorrhage | 1.37955622 |
54 | MP0003172_abnormal_lysosome_physiology | 1.37857769 |
55 | MP0002998_abnormal_bone_remodeling | 1.35163397 |
56 | MP0002722_abnormal_immune_system | 1.33807688 |
57 | MP0005076_abnormal_cell_differentiation | 1.33743010 |
58 | MP0005375_adipose_tissue_phenotype | 1.33249594 |
59 | MP0010155_abnormal_intestine_physiology | 1.32077483 |
60 | MP0002429_abnormal_blood_cell | 1.31872316 |
61 | MP0001545_abnormal_hematopoietic_system | 1.31460995 |
62 | MP0005397_hematopoietic_system_phenotyp | 1.31460995 |
63 | MP0001873_stomach_inflammation | 1.30844037 |
64 | MP0003075_altered_response_to | 1.30366526 |
65 | MP0000689_abnormal_spleen_morphology | 1.30160773 |
66 | MP0005623_abnormal_meninges_morphology | 1.29695722 |
67 | MP0003453_abnormal_keratinocyte_physiol | 1.29047158 |
68 | MP0002254_reproductive_system_inflammat | 1.26072324 |
69 | MP0000465_gastrointestinal_hemorrhage | 1.24494415 |
70 | MP0009278_abnormal_bone_marrow | 1.24048176 |
71 | MP0000604_amyloidosis | 1.23365104 |
72 | MP0002332_abnormal_exercise_endurance | 1.21782869 |
73 | MP0003693_abnormal_embryo_hatching | 1.16102836 |
74 | MP0002796_impaired_skin_barrier | 1.14911525 |
75 | MP0002971_abnormal_brown_adipose | 1.11810435 |
76 | MP0001727_abnormal_embryo_implantation | 1.11050213 |
77 | MP0009115_abnormal_fat_cell | 1.10198657 |
78 | MP0010678_abnormal_skin_adnexa | 1.09622637 |
79 | MP0001851_eye_inflammation | 1.09546541 |
80 | MP0005164_abnormal_response_to | 1.07647565 |
81 | MP0005174_abnormal_tail_pigmentation | 1.06698682 |
82 | MP0000703_abnormal_thymus_morphology | 1.04901064 |
83 | MP0003091_abnormal_cell_migration | 1.04521332 |
84 | MP0010307_abnormal_tumor_latency | 1.02711333 |
85 | MP0005166_decreased_susceptibility_to | 1.02655683 |
86 | MP0003566_abnormal_cell_adhesion | 1.01428651 |
87 | MP0003690_abnormal_glial_cell | 1.00761757 |
88 | MP0003941_abnormal_skin_development | 1.00473629 |
89 | MP0003183_abnormal_peptide_metabolism | 0.98641234 |
90 | MP0005058_abnormal_lysosome_morphology | 0.98120028 |
91 | MP0002877_abnormal_melanocyte_morpholog | 0.97684201 |
92 | MP0000490_abnormal_crypts_of | 0.95537078 |
93 | MP0008469_abnormal_protein_level | 0.94901437 |
94 | MP0000920_abnormal_myelination | 0.93886320 |
95 | MP0003329_amyloid_beta_deposits | 0.92808010 |
96 | MP0005390_skeleton_phenotype | 0.91818219 |
97 | MP0004808_abnormal_hematopoietic_stem | 0.91232652 |
98 | MP0004264_abnormal_extraembryonic_tissu | 0.88995354 |
99 | MP0005023_abnormal_wound_healing | 0.87139774 |
100 | MP0002277_abnormal_respiratory_mucosa | 0.86316039 |
101 | MP0000343_altered_response_to | 0.85839205 |
102 | MP0008874_decreased_physiological_sensi | 0.83810769 |
103 | MP0004130_abnormal_muscle_cell | 0.83664123 |
104 | MP0005167_abnormal_blood-brain_barrier | 0.83101419 |
105 | MP0003300_gastrointestinal_ulcer | 0.83042460 |
106 | MP0005248_abnormal_Harderian_gland | 0.82773808 |
107 | MP0010094_abnormal_chromosome_stability | 0.82287605 |
108 | MP0000627_abnormal_mammary_gland | 0.82192610 |
109 | MP0005310_abnormal_salivary_gland | 0.81908092 |
110 | MP0002396_abnormal_hematopoietic_system | 0.79726851 |
111 | MP0004782_abnormal_surfactant_physiolog | 0.76960299 |
112 | MP0005165_increased_susceptibility_to | 0.76840310 |
113 | MP0001881_abnormal_mammary_gland | 0.76030211 |
114 | MP0003077_abnormal_cell_cycle | 0.75859652 |
115 | MP0003795_abnormal_bone_structure | 0.75853185 |
116 | MP0008004_abnormal_stomach_pH | 0.75733504 |
117 | MP0003045_fibrosis | 0.75637699 |
118 | MP0003806_abnormal_nucleotide_metabolis | 0.74693374 |
119 | MP0000383_abnormal_hair_follicle | 0.74501961 |
120 | MP0001216_abnormal_epidermal_layer | 0.74344264 |
121 | MP0002019_abnormal_tumor_incidence | 0.72197211 |
122 | MP0004883_abnormal_blood_vessel | 0.71106036 |
123 | MP0008007_abnormal_cellular_replicative | 0.70002067 |
124 | MP0008058_abnormal_DNA_repair | 0.68851295 |
125 | MP0001191_abnormal_skin_condition | 0.68786322 |
126 | MP0000371_diluted_coat_color | 0.67621138 |
127 | MP0005621_abnormal_cell_physiology | 0.66079582 |
128 | MP0003111_abnormal_nucleus_morphology | 0.62319857 |
129 | MP0009384_cardiac_valve_regurgitation | 0.60732038 |
130 | MP0000350_abnormal_cell_proliferation | 0.60020024 |
131 | MP0000249_abnormal_blood_vessel | 0.59596527 |
132 | MP0009763_increased_sensitivity_to | 0.58436767 |
133 | MP0000733_abnormal_muscle_development | 0.56658928 |
134 | MP0003950_abnormal_plasma_membrane | 0.54023297 |
135 | MP0005171_absent_coat_pigmentation | 0.52609717 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Optic neuritis (HP:0100653) | 6.37313595 |
2 | Retrobulbar optic neuritis (HP:0100654) | 6.37313595 |
3 | Myositis (HP:0100614) | 6.18068097 |
4 | Recurrent abscess formation (HP:0002722) | 5.85827180 |
5 | Orchitis (HP:0100796) | 5.65738020 |
6 | Recurrent bacterial skin infections (HP:0005406) | 5.19964810 |
7 | Stomatitis (HP:0010280) | 4.49207163 |
8 | Eczematoid dermatitis (HP:0000976) | 4.43456026 |
9 | Mediastinal lymphadenopathy (HP:0100721) | 4.36609099 |
10 | Keratoconjunctivitis sicca (HP:0001097) | 4.20862843 |
11 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.05826113 |
12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.05826113 |
13 | Abnormality of glycolipid metabolism (HP:0010969) | 4.05826113 |
14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.99317933 |
15 | Keratoconjunctivitis (HP:0001096) | 3.72268195 |
16 | Obstructive lung disease (HP:0006536) | 3.17728594 |
17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.17728594 |
18 | Abnormality of macrophages (HP:0004311) | 3.16546267 |
19 | Epiphyseal dysplasia (HP:0002656) | 3.06619123 |
20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.01663634 |
21 | Pulmonary infiltrates (HP:0002113) | 2.96866728 |
22 | Vasculitis (HP:0002633) | 2.92408519 |
23 | Small epiphyses (HP:0010585) | 2.90036724 |
24 | Myocardial infarction (HP:0001658) | 2.82269813 |
25 | Hematochezia (HP:0002573) | 2.80315690 |
26 | Irregular epiphyses (HP:0010582) | 2.77797363 |
27 | Gingivitis (HP:0000230) | 2.74696371 |
28 | Basal ganglia calcification (HP:0002135) | 2.71666085 |
29 | Recurrent skin infections (HP:0001581) | 2.69589006 |
30 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.68351521 |
31 | Hemoptysis (HP:0002105) | 2.66959062 |
32 | Subacute progressive viral hepatitis (HP:0006572) | 2.66043820 |
33 | Poor head control (HP:0002421) | 2.65929375 |
34 | T lymphocytopenia (HP:0005403) | 2.65831734 |
35 | Vertebral compression fractures (HP:0002953) | 2.64174663 |
36 | Aseptic necrosis (HP:0010885) | 2.62556854 |
37 | Birth length less than 3rd percentile (HP:0003561) | 2.61983226 |
38 | Cerebral inclusion bodies (HP:0100314) | 2.61319568 |
39 | Arterial thrombosis (HP:0004420) | 2.60385308 |
40 | Chronic otitis media (HP:0000389) | 2.58391145 |
41 | Termporal pattern (HP:0011008) | 2.58057309 |
42 | Insidious onset (HP:0003587) | 2.58057309 |
43 | Encephalitis (HP:0002383) | 2.54041634 |
44 | Osteolytic defects of the hand bones (HP:0009699) | 2.53794975 |
45 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.53794975 |
46 | Abnormality of T cell number (HP:0011839) | 2.53388280 |
47 | Recurrent pneumonia (HP:0006532) | 2.51986579 |
48 | Thick nail (HP:0001805) | 2.51952307 |
49 | Abnormality of the pericardium (HP:0001697) | 2.51920626 |
50 | Recurrent viral infections (HP:0004429) | 2.51008088 |
51 | Tetraparesis (HP:0002273) | 2.50642662 |
52 | Neurofibrillary tangles (HP:0002185) | 2.49891385 |
53 | Recurrent fungal infections (HP:0002841) | 2.49109125 |
54 | Progressive external ophthalmoplegia (HP:0000590) | 2.48227297 |
55 | Resting tremor (HP:0002322) | 2.47840996 |
56 | Asymmetric septal hypertrophy (HP:0001670) | 2.47181585 |
57 | Agnosia (HP:0010524) | 2.46783004 |
58 | Loss of speech (HP:0002371) | 2.45681557 |
59 | Asymmetry of the thorax (HP:0001555) | 2.42832034 |
60 | Pustule (HP:0200039) | 2.41763563 |
61 | Gangrene (HP:0100758) | 2.40402772 |
62 | Petechiae (HP:0000967) | 2.39563101 |
63 | Prostate neoplasm (HP:0100787) | 2.38209707 |
64 | Anorexia (HP:0002039) | 2.37137103 |
65 | Leukocytosis (HP:0001974) | 2.32625969 |
66 | Micronodular cirrhosis (HP:0001413) | 2.32224602 |
67 | Meningitis (HP:0001287) | 2.31973411 |
68 | Dysostosis multiplex (HP:0000943) | 2.30878380 |
69 | Slow saccadic eye movements (HP:0000514) | 2.22993100 |
70 | Abnormality of the pleura (HP:0002103) | 2.21844108 |
71 | Papillary thyroid carcinoma (HP:0002895) | 2.20993149 |
72 | Anhidrosis (HP:0000970) | 2.17287684 |
73 | Curly hair (HP:0002212) | 2.16526627 |
74 | Absent frontal sinuses (HP:0002688) | 2.16428278 |
75 | Fatigue (HP:0012378) | 2.15751318 |
76 | Keratitis (HP:0000491) | 2.15674303 |
77 | Amyloidosis (HP:0011034) | 2.12743447 |
78 | Distal lower limb muscle weakness (HP:0009053) | 2.11304341 |
79 | Ankyloglossia (HP:0010296) | 2.08872960 |
80 | Colitis (HP:0002583) | 2.07357475 |
81 | Increased IgM level (HP:0003496) | 2.06908926 |
82 | Esophageal varix (HP:0002040) | 2.03697404 |
83 | Hyporeflexia of lower limbs (HP:0002600) | 2.03697229 |
84 | Eosinophilia (HP:0001880) | 1.99052451 |
85 | Spondylolisthesis (HP:0003302) | 1.98838816 |
86 | Periodontitis (HP:0000704) | 1.98100741 |
87 | Disinhibition (HP:0000734) | 1.97062388 |
88 | Increased CSF protein (HP:0002922) | 1.96654089 |
89 | Bone pain (HP:0002653) | 1.95994935 |
90 | Abnormality of the vertebral endplates (HP:0005106) | 1.95373211 |
91 | Apathy (HP:0000741) | 1.94658230 |
92 | Recurrent lower respiratory tract infections (HP:0002783) | 1.94493546 |
93 | Diminished motivation (HP:0000745) | 1.92771903 |
94 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.90849305 |
95 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.90634768 |
96 | Glomerulopathy (HP:0100820) | 1.89400197 |
97 | Mucopolysacchariduria (HP:0008155) | 1.88907861 |
98 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.88907861 |
99 | Increased cerebral lipofuscin (HP:0011813) | 1.88742374 |
100 | Abnormality of eosinophils (HP:0001879) | 1.87779102 |
101 | Cellulitis (HP:0100658) | 1.87563384 |
102 | Deep philtrum (HP:0002002) | 1.86042083 |
103 | Progressive neurologic deterioration (HP:0002344) | 1.85794499 |
104 | Viral hepatitis (HP:0006562) | 1.85200602 |
105 | Abnormality of oral frenula (HP:0000190) | 1.85070201 |
106 | Spontaneous hematomas (HP:0007420) | 1.84411503 |
107 | Inflammation of the large intestine (HP:0002037) | 1.83554331 |
108 | Abnormality of the columella (HP:0009929) | 1.81226233 |
109 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.80932775 |
110 | Neuronal loss in central nervous system (HP:0002529) | 1.80314202 |
111 | Thyroiditis (HP:0100646) | 1.79963299 |
112 | Axonal loss (HP:0003447) | 1.79922540 |
113 | Thrombocytosis (HP:0001894) | 1.79725706 |
114 | Subaortic stenosis (HP:0001682) | 1.78779674 |
115 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.78779674 |
116 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.78162884 |
117 | Interstitial pulmonary disease (HP:0006530) | 1.77987360 |
118 | Arthralgia (HP:0002829) | 1.77638959 |
119 | Stomach cancer (HP:0012126) | 1.77432187 |
120 | Abnormality of the common coagulation pathway (HP:0010990) | 1.76357178 |
121 | Vacuolated lymphocytes (HP:0001922) | 1.76305972 |
122 | Polycythemia (HP:0001901) | 1.73840554 |
123 | Personality changes (HP:0000751) | 1.73218819 |
124 | Nuclear cataract (HP:0100018) | 1.72973953 |
125 | Parakeratosis (HP:0001036) | 1.72892030 |
126 | Gastrointestinal inflammation (HP:0004386) | 1.72885535 |
127 | Increased connective tissue (HP:0009025) | 1.72796754 |
128 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.71510784 |
129 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.71510784 |
130 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.71510784 |
131 | Hyperparathyroidism (HP:0000843) | 1.71424149 |
132 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.69707315 |
133 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.69648667 |
134 | Barrel-shaped chest (HP:0001552) | 1.68631648 |
135 | Increased variability in muscle fiber diameter (HP:0003557) | 1.68164158 |
136 | Flattened epiphyses (HP:0003071) | 1.67955566 |
137 | Hypergammaglobulinemia (HP:0010702) | 1.67719604 |
138 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.65948548 |
139 | Hepatosplenomegaly (HP:0001433) | 1.65440258 |
140 | Pathologic fracture (HP:0002756) | 1.65320133 |
141 | Flat capital femoral epiphysis (HP:0003370) | 1.64733458 |
142 | Increased serum ferritin (HP:0003281) | 1.64563880 |
143 | Short nail (HP:0001799) | 1.63249954 |
144 | J-shaped sella turcica (HP:0002680) | 1.62897126 |
145 | Distal lower limb amyotrophy (HP:0008944) | 1.62556749 |
146 | Difficulty running (HP:0009046) | 1.61561290 |
147 | Autoimmune hemolytic anemia (HP:0001890) | 1.60649436 |
148 | Menstrual irregularities (HP:0000858) | 1.60572486 |
149 | Amaurosis fugax (HP:0100576) | 1.60271255 |
150 | Vitreoretinal degeneration (HP:0000655) | 1.60224408 |
151 | Stenosis of the external auditory canal (HP:0000402) | 1.57802900 |
152 | Syringomyelia (HP:0003396) | 1.57704519 |
153 | Spinal cord lesions (HP:0100561) | 1.57704519 |
154 | Polyneuropathy (HP:0001271) | 1.57625328 |
155 | Premature loss of primary teeth (HP:0006323) | 1.56916377 |
156 | Metaphyseal cupping (HP:0003021) | 1.54266624 |
157 | Dry hair (HP:0011359) | 1.53973077 |
158 | Osteomyelitis (HP:0002754) | 1.53838733 |
159 | Lymphoma (HP:0002665) | 1.53559186 |
160 | Severe combined immunodeficiency (HP:0004430) | 1.52896790 |
161 | Granulocytopenia (HP:0001913) | 1.51972487 |
162 | Flared metaphyses (HP:0003015) | 1.51797887 |
163 | 11 pairs of ribs (HP:0000878) | 1.51765809 |
164 | Genu varum (HP:0002970) | 1.50402954 |
165 | Vertigo (HP:0002321) | 1.49480668 |
166 | Abnormality of the prostate (HP:0008775) | 1.49099414 |
167 | Arterial tortuosity (HP:0005116) | 1.48963800 |
168 | Hypoplastic pelvis (HP:0008839) | 1.47294681 |
169 | Mild short stature (HP:0003502) | 1.47100226 |
170 | Gastrointestinal infarctions (HP:0005244) | 1.46670078 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 5.70830857 |
2 | PBK | 3.36816399 |
3 | IRAK3 | 2.99262158 |
4 | TXK | 2.97981818 |
5 | RIPK4 | 2.96291522 |
6 | BLK | 2.78704528 |
7 | TBK1 | 2.53723662 |
8 | TRIB3 | 2.53281717 |
9 | CLK1 | 2.28041660 |
10 | MAP3K13 | 2.26764856 |
11 | IKBKB | 2.21995688 |
12 | JAK3 | 2.19080782 |
13 | MST4 | 2.18492379 |
14 | PIM2 | 2.09000695 |
15 | MAP2K3 | 2.08301981 |
16 | NME2 | 2.03086690 |
17 | ACVR1B | 1.93340849 |
18 | MELK | 1.91385512 |
19 | IRAK4 | 1.86700118 |
20 | MAP4K1 | 1.77849081 |
21 | CDK8 | 1.73660191 |
22 | TYK2 | 1.64521107 |
23 | ERN1 | 1.58907188 |
24 | PRPF4B | 1.52422314 |
25 | SIK3 | 1.52166965 |
26 | PIM1 | 1.49535955 |
27 | MAP3K3 | 1.49380830 |
28 | ITK | 1.47014083 |
29 | MARK3 | 1.46725332 |
30 | CHUK | 1.44286795 |
31 | IKBKE | 1.43518007 |
32 | TTN | 1.43130532 |
33 | LATS2 | 1.42055651 |
34 | PAK4 | 1.40260003 |
35 | MST1R | 1.36048438 |
36 | IRAK2 | 1.34476353 |
37 | PDGFRA | 1.28087577 |
38 | MAP3K1 | 1.27944587 |
39 | MATK | 1.26705556 |
40 | JAK1 | 1.25667399 |
41 | MAP3K12 | 1.25619342 |
42 | EIF2AK2 | 1.24605094 |
43 | STK24 | 1.23559212 |
44 | LCK | 1.23114142 |
45 | WEE1 | 1.22510328 |
46 | BMX | 1.21683765 |
47 | RPS6KA4 | 1.20813299 |
48 | TAOK2 | 1.19987559 |
49 | HCK | 1.18228902 |
50 | MAP2K6 | 1.17045080 |
51 | NEK9 | 1.16559099 |
52 | EPHB1 | 1.15964030 |
53 | RAF1 | 1.15234715 |
54 | PLK2 | 1.13713958 |
55 | ERBB3 | 1.13385024 |
56 | TRPM7 | 1.12377458 |
57 | SYK | 1.11831574 |
58 | NUAK1 | 1.08207534 |
59 | STK10 | 1.06260763 |
60 | YES1 | 1.06008040 |
61 | STK4 | 1.05625369 |
62 | BRSK2 | 1.05185231 |
63 | NLK | 1.04631056 |
64 | KIT | 1.04480476 |
65 | MAP3K6 | 1.04062064 |
66 | FGFR4 | 1.02552724 |
67 | EPHA3 | 1.01294176 |
68 | LYN | 1.00592103 |
69 | PDPK1 | 0.96554560 |
70 | TESK1 | 0.96120166 |
71 | CDK9 | 0.95312639 |
72 | EIF2AK1 | 0.93120805 |
73 | BRD4 | 0.92345924 |
74 | SMG1 | 0.91767928 |
75 | CSK | 0.91311336 |
76 | CDK4 | 0.89859877 |
77 | NEK6 | 0.86868405 |
78 | FGFR3 | 0.86859928 |
79 | ZAP70 | 0.86303561 |
80 | MAP3K9 | 0.86242434 |
81 | BTK | 0.85466329 |
82 | PRKG2 | 0.85386802 |
83 | RIPK1 | 0.84520054 |
84 | BMPR2 | 0.83295401 |
85 | RPS6KB2 | 0.83124003 |
86 | CSF1R | 0.82325949 |
87 | PKN2 | 0.80929768 |
88 | CDK6 | 0.80815473 |
89 | MOS | 0.79855569 |
90 | FGR | 0.79101889 |
91 | STK3 | 0.78846369 |
92 | SIK2 | 0.76135271 |
93 | ARAF | 0.75273401 |
94 | ICK | 0.74358736 |
95 | RET | 0.74308482 |
96 | TEC | 0.73633024 |
97 | PDK1 | 0.65634471 |
98 | EPHA2 | 0.65008925 |
99 | IRAK1 | 0.63631971 |
100 | ABL1 | 0.62191611 |
101 | ALK | 0.61872105 |
102 | PIK3CG | 0.61380728 |
103 | PRKCQ | 0.60884519 |
104 | DMPK | 0.60537381 |
105 | FES | 0.60007208 |
106 | PRKCD | 0.59611621 |
107 | KSR1 | 0.57929918 |
108 | MAP3K8 | 0.57556545 |
109 | PTK2 | 0.56879026 |
110 | MTOR | 0.55311352 |
111 | SGK3 | 0.54548872 |
112 | EIF2AK3 | 0.53502673 |
113 | LRRK2 | 0.52948356 |
114 | TAOK1 | 0.51584184 |
115 | ATR | 0.50204982 |
116 | GRK7 | 0.49716885 |
117 | SCYL2 | 0.49086541 |
118 | VRK1 | 0.49040892 |
119 | EEF2K | 0.48817024 |
120 | STK38L | 0.48737451 |
121 | CDK12 | 0.48590586 |
122 | PTK6 | 0.48527018 |
123 | CAMKK2 | 0.48344923 |
124 | DDR2 | 0.45314679 |
125 | CHEK2 | 0.44565776 |
126 | JAK2 | 0.42090603 |
127 | MAPKAPK2 | 0.41604992 |
128 | ROCK2 | 0.41160317 |
129 | PIK3CA | 0.40851446 |
130 | MAP3K2 | 0.40099165 |
131 | PDGFRB | 0.37182334 |
132 | ZAK | 0.36729044 |
133 | MAP3K5 | 0.35822400 |
134 | EGFR | 0.35215150 |
135 | PLK3 | 0.34007724 |
136 | MKNK1 | 0.33910422 |
137 | ADRBK2 | 0.33822164 |
138 | KSR2 | 0.32404379 |
139 | SGK1 | 0.30199801 |
140 | TNIK | 0.29590309 |
141 | MKNK2 | 0.28907064 |
142 | SIK1 | 0.27045839 |
143 | ERBB4 | 0.26477316 |
144 | RPS6KA5 | 0.26014907 |
145 | INSR | 0.23935830 |
146 | CDC7 | 0.23663733 |
147 | BRSK1 | 0.23376583 |
148 | PAK6 | 0.22961973 |
149 | TGFBR2 | 0.22485955 |
150 | MET | 0.22305656 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.19575566 |
2 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.48991948 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.47740359 |
4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.44733111 |
5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.41347936 |
6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.39656142 |
7 | Allograft rejection_Homo sapiens_hsa05330 | 2.38226670 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.22104051 |
9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.19677365 |
10 | Legionellosis_Homo sapiens_hsa05134 | 2.13893941 |
11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.95591287 |
12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.94384777 |
13 | Malaria_Homo sapiens_hsa05144 | 1.92161022 |
14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.91338462 |
15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.86100787 |
16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.83638628 |
17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.75452872 |
18 | Measles_Homo sapiens_hsa05162 | 1.71242557 |
19 | Pertussis_Homo sapiens_hsa05133 | 1.71198047 |
20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.70413562 |
21 | Tuberculosis_Homo sapiens_hsa05152 | 1.59975420 |
22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.59925252 |
23 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.54818714 |
24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.50976270 |
25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.48922189 |
26 | Bladder cancer_Homo sapiens_hsa05219 | 1.44475807 |
27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.41105831 |
28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.39153370 |
29 | Thyroid cancer_Homo sapiens_hsa05216 | 1.36025752 |
30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33974704 |
31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.30410735 |
32 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.28652724 |
33 | Salmonella infection_Homo sapiens_hsa05132 | 1.28159036 |
34 | Hepatitis B_Homo sapiens_hsa05161 | 1.27976518 |
35 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.27061826 |
36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.25421226 |
37 | Influenza A_Homo sapiens_hsa05164 | 1.22693780 |
38 | Phagosome_Homo sapiens_hsa04145 | 1.21516927 |
39 | Endometrial cancer_Homo sapiens_hsa05213 | 1.21357797 |
40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21315302 |
41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17262833 |
42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17103119 |
43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16294750 |
44 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12718239 |
45 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.11542079 |
46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09594439 |
47 | Shigellosis_Homo sapiens_hsa05131 | 1.09278550 |
48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08092467 |
49 | Apoptosis_Homo sapiens_hsa04210 | 1.07769100 |
50 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.06045656 |
51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.05884209 |
52 | Asthma_Homo sapiens_hsa05310 | 1.05718184 |
53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.04614433 |
54 | Lysosome_Homo sapiens_hsa04142 | 1.00567953 |
55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.00475857 |
56 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98510026 |
57 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.97518540 |
58 | Glioma_Homo sapiens_hsa05214 | 0.96714861 |
59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93519562 |
60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89493609 |
61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.89379016 |
62 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.88909981 |
63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88372996 |
64 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86847669 |
65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84996279 |
66 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.84492364 |
67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81382766 |
68 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.81151214 |
69 | Insulin resistance_Homo sapiens_hsa04931 | 0.77645473 |
70 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.77083516 |
71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.76464500 |
72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74536775 |
73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74099662 |
74 | Amoebiasis_Homo sapiens_hsa05146 | 0.73657398 |
75 | Endocytosis_Homo sapiens_hsa04144 | 0.73344063 |
76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72534769 |
77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71724509 |
78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71050000 |
79 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.68159115 |
80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67771430 |
81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67584196 |
82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.67347676 |
83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67049569 |
84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65181452 |
85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65087889 |
86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65043213 |
87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64672129 |
88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63738366 |
89 | Hepatitis C_Homo sapiens_hsa05160 | 0.63579031 |
90 | DNA replication_Homo sapiens_hsa03030 | 0.62899032 |
91 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62791650 |
92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61936355 |
93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61856151 |
94 | Proteasome_Homo sapiens_hsa03050 | 0.58852119 |
95 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.58587296 |
96 | Cell cycle_Homo sapiens_hsa04110 | 0.58149509 |
97 | Protein export_Homo sapiens_hsa03060 | 0.57869899 |
98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57550965 |
99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56272088 |
100 | Homologous recombination_Homo sapiens_hsa03440 | 0.56147361 |
101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56063807 |
102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55963399 |
103 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55881237 |
104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53921153 |
105 | Mismatch repair_Homo sapiens_hsa03430 | 0.53082499 |
106 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51203209 |
107 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49957717 |
108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49046664 |
109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48824630 |
110 | Platelet activation_Homo sapiens_hsa04611 | 0.47318100 |
111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47235981 |
112 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.45575094 |
113 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.44203837 |
114 | RNA polymerase_Homo sapiens_hsa03020 | 0.43573722 |
115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42625223 |
116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42260790 |
117 | Focal adhesion_Homo sapiens_hsa04510 | 0.41138135 |
118 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.40754233 |
119 | Spliceosome_Homo sapiens_hsa03040 | 0.40493481 |
120 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39785417 |
121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39246614 |
122 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38581543 |
123 | Prostate cancer_Homo sapiens_hsa05215 | 0.36812927 |
124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36081668 |
125 | Adherens junction_Homo sapiens_hsa04520 | 0.34813751 |
126 | Prion diseases_Homo sapiens_hsa05020 | 0.34382031 |
127 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34198971 |
128 | RNA degradation_Homo sapiens_hsa03018 | 0.33793673 |
129 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33707220 |
130 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32740841 |
131 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.31556346 |